Safety and efficacy of simeprevir plus sofosbuvir with or without ribavirin in patients with decompensated genotype 1 hepatitis C cirrhosis-Reference-Cited by-同舟云学术

Safety and efficacy of simeprevir plus sofosbuvir with or without ribavirin in patients with decompensated genotype 1 hepatitis C cirrhosis

Published:2016-02-25 Issue:3 Volume:22 Page:281-286
ISSN:1527-6465
Container-title:Liver Transplantation
language:en
Short-container-title:Liver Transpl

Author:

Modi Apurva A.¹,Nazario Hector²,Trotter James F.¹,Gautam Manjushree¹,Weinstein Jeffrey²,Mantry Parvez²,Barnes Maisha²,Habib Adil²,McAfee Jean¹,Teachenor Olga²,Tujague Lauren²,Gonzalez Stevan¹

Affiliation:

1. Liver Consultants of Texas; Baylor Simmons Transplant Center; Fort Worth TX

2. Liver Institute; Methodist Dallas Medical Center; Dallas TX

Publisher

Wiley

Subject

Transplantation,Hepatology,Surgery

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/lt.24324/fullpdf

Reference24 articles.

1. Hepatitis C virus infection;Lauer;N Engl J Med,2001

2. Report of a WHO consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium;Global surveillance and control of hepatitis C;J Viral Hepat,1999

3. The changing epidemiology of hepatitis C virus infection in the United States: National Health and Nutrition Examination Survey 2001 though 2010;Ditah;J Hepatol,2014

4. Antiviral therapy of patients with decompensated cirrhosis to prevent recurrence of hepatitis C after liver transplantation;Forns;J Hepatol,2003

5. A randomized controlled trial of pretransplant antiviral therapy to prevent recurrence of hepatitis c after liver transplantation;Everson;Hepatology,2013

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Artificial intelligence predicts direct-acting antivirals failure among hepatitis C virus patients: A nationwide hepatitis C virus registry program;Clinical and Molecular Hepatology;2023-01-01

2. Direct-Acting Antivirals for HCV Treatment in Decompensated Liver Cirrhosis Patients: A Systematic Review and Meta-Analysis;Journal of Personalized Medicine;2022-09-15

3. Results of interferon-free treatment for HCV-infected patients with decompensated cirrhosis from a Brazilian real-life cohort;Medicine;2022-09-02

4. Successful treatment of hepatitis C genotype 4 using sofosbuvir, daclatasvir, simeprevir and ribavirin in Egyptian patients with direct-acting antiviral agent treatment failure;Clinical and Experimental Hepatology;2022

5. The risks of hepatocellular carcinoma and variceal bleeding after HCV eradication with direct-acting antiviral therapy: a propensity score analysis;Revista Medico-Chirurgicala;2021-03-30